ハイライト＆特長
What is happening at Global Clinical Trial Disclosure and Data Transparency Conference
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
- Enhance Understanding: Equip participants with the latest knowledge and updates about clinical trial disclosure standards and practices, focusing on regulatory compliance across different regions
- Promote Best Practices: Share and promote the best practices for maximizing transparency in clinical trials, including the use of plain language summaries and innovative tools like the EU Clinical Trials Information System (CTIS)
- Encourage Networking and Collaboration: Facilitate networking opportunities among professionals from biopharma companies, regulators, and other stakeholders to foster collaboration and sharing of insights
- Support Implementation of Technologies: Explore and discuss the integration of advanced technologies in improving the transparency and efficiency of clinical trial processes
- Increase Compliance and Awareness: Highlight and address the enforcement initiatives and legal consequences of non-compliance with clinical trial transparency requirements
- Advocate for Patient-Centric Approaches: Emphasize the importance of patient-centric approaches in clinical trial communication, ensuring that trial results and summaries are accessible and understandable to non-specialist audiences
- Regulatory Updates: Critical updates on new and evolving regulatory requirements across various regions, which is critical for ensuring compliance and staying abreast of changes that could impact how clinical trials are conducted and reported
- Expert Insights: Gain direct insights from industry leaders and regulators, offering attendees a unique opportunity to learn from and interact with key thought leaders
- Technological Advancements: Emphasis on the latest advancements in technology, including the application of artificial intelligence in clinical trial transparency. Attendees will explore innovative tools and methodologies that have the potential to transform their operational processes
- Patient-Centric Approaches: Understanding and implementing patient-centric communication strategies, including plain language summaries, is increasingly important. This conference will provide strategies and examples of how to effectively communicate with trial participants and the public
- Global Perspective: The global focus of the conference helps attendees understand and navigate the international landscape of clinical trial transparency, which is particularly important for organizations that operate or plan to operate on a global scale
Hosted Event/Non-CE: Case Study Spotlight Sponsored by TrialAssure: The Role of AI in Safeguarding Privacy and Confidential Company Information (CCI)
September 23 - 3:25-3:55PM
We will explore the effectiveness of TrialAssure ANONYMIZE® 3.0 to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI) to protect patient and company confidential information. The tool automates anonymization, balancing the need for data privacy while maintaining the utility of the data. ANONYMIZE reduces the time and effort required for data preparation and minimizes re-identification risks, supporting both regulatory compliance and the integrity of clinical research. TrialAssure ANONYMIZE 3.0 gives users the ability to anonymize PDFs and other document types, including emails and Microsoft Office documents (Word, Excel, and PowerPoint). For data, ANONYMIZE 3.0 supports SAS, XPT, Excel, and CSV file formats.